1
|
Cui S, Xiong H, Feng Z, Chu Y, Que C, Qin J, Pan Y, Yu K, Jia L, Yao X, Liao J, Huo D, Guo C, Zhao H, Xu M, Tian Y, Peng Q, Li F, Xu H, Hong R, Zhang D, Wang G, Yang P, Gao GF, Wang Q. Severe pigeon paramyxovirus 1 infection in a human case with probable post-COVID-19 condition. Emerg Microbes Infect 2023; 12:2251600. [PMID: 37606967 PMCID: PMC10469423 DOI: 10.1080/22221751.2023.2251600] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2023] [Revised: 08/16/2023] [Accepted: 08/20/2023] [Indexed: 08/23/2023]
Abstract
Pigeon paramyxovirus 1 (PPMV-1) is an antigenic host variant of avian paramyxovirus 1. Sporadic outbreaks of PPMV-1 infection have occurred in pigeons in China; however, few cases of human PPMV-1 infection have been reported. The purpose of this article is to report a case of severe human PPMV-1 infection in an individual with probable post-COVID-19 syndrome (long COVID) who presented with rapidly progressing pulmonary infection. The patient was a 66-year-old man who was admitted to the intensive care unit 11 days after onset of pneumonia and recovered 64 days after onset. PPMV-1 was isolated from the patient's sputum and in cloacal smear samples from domesticated pigeons belonging to the patient's neighbour. Residual severe acute respiratory syndrome coronavirus 2 was detected in respiratory and anal swab samples from the patient. Sequencing analyses revealed that the PPMV-1 genome belonged to genotype VI.2.1.1.2.2 and had the 112RRQKRF117 motif in the cleavage site of the fusion protein, which is indicative of high virulence. This case of cross-species transmission of PPMV-1 from a pigeon to a human highlights the risk of severe PPMV-1 infection in immunocompromised patients, especially those with long COVID. Enhanced surveillance for increased risk of severe viral infection is warranted in this population.
Collapse
Affiliation(s)
- Shujuan Cui
- Beijing Center for Disease Prevention and Control, Beijing, People’s Republic of China
- Beijing Research Center for Respiratory Infectious Diseases, Beijing, People’s Republic of China
| | - Hui Xiong
- Department of Emergency, Peking University First Hospital, Beijing, People’s Republic of China
| | - Zhaomin Feng
- Beijing Center for Disease Prevention and Control, Beijing, People’s Republic of China
- Beijing Research Center for Respiratory Infectious Diseases, Beijing, People’s Republic of China
| | - Yanhui Chu
- Xicheng District Center for Disease Prevention and Control, Beijing, People’s Republic of China
| | - Chengli Que
- Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, People’s Republic of China
| | - Jingning Qin
- Xicheng District Center for Disease Prevention and Control, Beijing, People’s Republic of China
| | - Yang Pan
- Beijing Center for Disease Prevention and Control, Beijing, People’s Republic of China
| | - Kunyao Yu
- Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, People’s Republic of China
| | - Lei Jia
- Beijing Center for Disease Prevention and Control, Beijing, People’s Republic of China
| | - Xi Yao
- Department of infection control, Peking University First Hospital, Beijing, People’s Republic of China
| | - Jiping Liao
- Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, People’s Republic of China
| | - Da Huo
- Beijing Center for Disease Prevention and Control, Beijing, People’s Republic of China
| | - Cuiyan Guo
- Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, People’s Republic of China
| | - Hao Zhao
- Beijing Center for Disease Prevention and Control, Beijing, People’s Republic of China
| | - Meng Xu
- Department of Emergency, Peking University First Hospital, Beijing, People’s Republic of China
| | - Yanan Tian
- Department of Emergency, Peking University First Hospital, Beijing, People’s Republic of China
| | - Qing Peng
- Department of neurology, Peking University First Hospital, Beijing, People’s Republic of China
| | - Fu Li
- Beijing Center for Disease Prevention and Control, Beijing, People’s Republic of China
| | - Hui Xu
- Beijing Center for Disease Prevention and Control, Beijing, People’s Republic of China
| | - Runsheng Hong
- Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, People’s Republic of China
| | - Daitao Zhang
- Beijing Center for Disease Prevention and Control, Beijing, People’s Republic of China
- Beijing Research Center for Respiratory Infectious Diseases, Beijing, People’s Republic of China
| | - Guangfa Wang
- Department of Respiratory and Critical Care Medicine, Peking University First Hospital, Beijing, People’s Republic of China
| | - Peng Yang
- Beijing Center for Disease Prevention and Control, Beijing, People’s Republic of China
- Beijing Research Center for Respiratory Infectious Diseases, Beijing, People’s Republic of China
| | - George F. Gao
- CAS Key Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Center for Influenza Research and Early-warning (CASCIRE), CAS-TWAS Center of Excellence for Emerging Infectious Diseases (CEEID), Chinese Academy of Sciences, Beijing, People’s Republic of China
- University of Chinese Academy of Sciences, Beijing, People’s Republic of China
| | - Quanyi Wang
- Beijing Center for Disease Prevention and Control, Beijing, People’s Republic of China
- Beijing Research Center for Respiratory Infectious Diseases, Beijing, People’s Republic of China
- School of Public Health, Capital Medical University, Beijing, People’s Republic of China
| |
Collapse
|